Catalyst Biosciences Inc (CBIO.OQ)
CBIO.OQ on NASDAQ Stock Exchange Capital Market
8.61USD
9:58pm IST
8.61USD
9:58pm IST
Change (% chg)
$-0.19 (-2.16%)
$-0.19 (-2.16%)
Prev Close
$8.80
$8.80
Open
$8.79
$8.79
Day's High
$8.79
$8.79
Day's Low
$8.51
$8.51
Volume
9,218
9,218
Avg. Vol
52,215
52,215
52-wk High
$33.02
$33.02
52-wk Low
$6.20
$6.20
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.00 | -0.644 |
| Jun '18 | 0.00 | -0.543 | |
| Mar '18 | 0.01 | -0.561 | |
| FY 2017 | Dec '17 | 0.32 | -1.261 |
| Sep '17 | 0.32 | -1.344 | |
| Jun '17 | 0.11 | -2.534 | |
| Mar '17 | 0.27 | -4.567 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Jun-19 | 2 | 0.50 | 1.00 | 0.00 | -- |
| Year Ending Dec-19 | 2 | 0.80 | 1.60 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 2 | -0.91 | -0.72 | -1.10 | -- |
| Quarter Ending Jun-19 | 2 | -0.98 | -0.76 | -1.20 | -- |
| Year Ending Dec-19 | 2 | -3.97 | -3.25 | -4.69 | -5.76 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 30.48 | 33.70 | |
| P/E High - Last 5 Yrs. | -- | 44.98 | 49.87 | |
| P/E Low - Last 5 Yrs. | -- | 23.63 | 24.25 | |
| Beta | 1.35 | 0.90 | 0.90 | |
| Price to Sales (TTM) | 43.72 | 4.12 | 6.29 | |
| Price to Book (MRQ) | 0.81 | 5.10 | 5.26 | |
| Price to Tangible Book (MRQ) | 0.81 | 5.85 | 6.77 | |
| Price to Cash Flow (TTM) | -- | 24.01 | 24.98 | |
| % Owned Institutions | 33.39 | 0.90 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.49 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 1.51 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 4.15 | 4.85 | |
| Payout Ratio(TTM) | -- | 43.91 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 1.83 | 4.31 | 12.75 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 28.90 | 4.07 | 5.84 | |
| Sales - 5 Yr. Growth Rate | -66.71 | 10.91 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 59.98 | 44.94 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 43.85 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.31 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | -20.03 | 15.88 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.15 | 2.25 |
| Current Ratio (MRQ) | 4.23 | 2.97 | 3.08 |
| LT Debt to Equity (MRQ) | 0.00 | 8.84 | 11.38 |
| Total Debt to Equity (MRQ) | 19.01 | 12.89 | 16.12 |
| Interest Coverage (TTM) | -32.83 | 33.79 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 53.68 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | -- | 51.67 | 52.18 | |
| EBITD Margin (TTM) | -3,698.75 | -- | -- | |
| EBITD - 5 Yr. Avg | -82.54 | 17.96 | 12.87 | |
| Operating Margin (TTM) | -3,745.02 | 14.31 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -96.22 | 14.24 | 8.31 | |
| Pre-Tax Margin (TTM) | -3,298.22 | 14.85 | 7.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -88.84 | 14.68 | 8.61 | |
| Net Profit Margin (TTM) | -3,298.22 | 11.08 | 3.30 | |
| Net Profit Margin - 5 Yr. Avg. | -88.67 | 11.02 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 23.02 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.16 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 56,200 | 957,645,487 | 842,398,385 | |
| Net Income/Employee (TTM) | -1,853,600 | 113,564,537 | 99,842,801 | |
| Receivable Turnover (TTM) | 1.88 | 5.71 | 5.71 | |
| Inventory Turnover (TTM) | -- | 2.61 | 3.47 | |
| Asset Turnover (TTM) | 0.01 | 0.97 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -38.28 | 11.52 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -9.94 | 12.92 | 12.20 | |
| Return on Investment (TTM) | -68.74 | 14.95 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -12.47 | 16.84 | 15.87 | |
| Return on Equity (TTM) | -83.55 | 16.27 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -16.87 | 17.77 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -77.20 | -8.63 | -66.71 |
| EPS (TTM) % | 56.50 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Catalyst Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 61.02 | 55.47 | 98 | 22 |
| 13 Week | 23.64 | 17.62 | 88 | 39 |
| 26 Week | 4.59 | -3.36 | 62 | 33 |
| 52 Week | -67.80 | -72.70 | 4 | 9 |
| YTD | -41.55 | -48.67 | 9 | 26 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 73.31% |
| # of Holders: | 95 |
| Total Shares Held: | 8,754,662 |
| 3 Mo. Net Change: | -377,074 |
| # New Positions: | 10 |
| # Closed Positions: | 16 |
| # Increased Positions: | 41 |
| # Reduced Positions: | 42 |
| # Net Buyers: | -1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.